Late HIV diagnosis in Europe: A call for increased testing and awareness among general practitioners

References

• Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio Monforte A. Decline in the AIDS and death rates in the EuroSIDA study: An observational study. Lancet 2003;362:22–9.
   PubMed Web of Science ®Google Scholar
• Bhaskaran K, Hamouda O, Sannes M, Boufassa F, Johnson AM, Lambert PC, . Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA 2008;300:51–9.
   PubMed Web of Science ®Google Scholar
• May M, Gompels M, Delpech V, Porter K, Post F, Johnson M, . Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK collaborative HIV cohort (UK CHIC) Study. Br Med J. 2011;343:d6016.
   PubMed Web of Science ®Google Scholar
• Hamers FF, Phillips AN. Diagnosed and undiagnosed HIV-infected populations in Europe. HIV Med. 2008;9:6–12.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global report: UNAIDS report on the global AIDS epidemic 2010. Geneva (Switzerland): World Health Organization; 2010. Available at www.unaids.org/documents/20101123_globalreport_em.pdf (accessed 8 March 2012).
   Google Scholar
• European Centre for Disease Prevention and Control/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2010. Stockholm, Sweden: ECDC; 2011. Available at http://ecdc.europa.eu/en/publications/Publications/111129_SUR_Annual_HIV_Report.pdf (accessed 8 March 2012).
   Google Scholar
• Antinori A, Johnson M, Moreno S, Yazdanpanah Y, Rockstroh JK. Report of a European Working Group on late presentation with HIV infection: Recommendations and regional variation. Antivir Ther. 2010;15:31–5.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach—2010 revision. Austria: World Health Organization; 2010. Available at http://whqlibdoc.who.int/publications/2010/ 9789241599764_eng.pdf (accessed 8 March 2012).
   Google Scholar
• Clumeck N, Pozniak A, Raffi F, on behalf of the EACS Executive Committee. European AIDS clinical society (EACS) guidelines for the clinical management and treatment of HIV-infected adults. HIV Med. 2008;9:65–71.
   PubMed Web of Science ®Google Scholar
• Girardi E, Sabin CA, Monforte AD. Late diagnosis of HIV infection: Epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr. 2007;46:S3–8.
   PubMed Web of Science ®Google Scholar
• Delpierre C, Dray-Spira R, Cuzin L, Marchou B, Massip P, Lang T, . Correlates of late HIV diagnosis: Implications for testing policy. Int J of STD & AIDS 2007;18:312–7.
   PubMed Web of Science ®Google Scholar
• Sullivan AK, Curtis H, Sabin CA, Johnson MA. Newly diagnosed HIV infections: Review in UK and Ireland. Br Med J. 2005;330:1301–2.
   PubMed Web of Science ®Google Scholar
• Brannstrom J, Akerlund B, Arneborn M, Blaxhult A, Giesecke J. Patients unaware of their HIV infection until AIDS diagnosis in Sweden 1996–2002. A remaining problem in the highly active antiretroviral therapy era. Int J of STD & AIDS 2005;16:702–6.
   PubMed Web of Science ®Google Scholar
• Longo B, Pezzotti P, Boros S, Urciuoli R, Rezza G. Increasing proportion of late testers among AIDS cases in Italy, 1996–2002. AIDS Care 2005;17:834–41.
   PubMed Web of Science ®Google Scholar
• Likatavicius G, Van de Laar MJ. HIV infection and AIDS in the European Union and European economic area, 2010. Euro Surveill 2011;16.
   Google Scholar
• Castilla J, Sobrino P, De La Fuente L, Noguer I, Guerra L, Parras F. Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: Consequences for AIDS incidence. AIDS 2002;16:1945–51.
   PubMed Web of Science ®Google Scholar
• Lanoy E, Mary-Krause M, Tattevin P, Perbost I, Poizot-Martin I, Dupont C; ANRS C004 French hospital database on HIV clinical epidemiological group. Frequency, determinants and consequences of delayed access to care for HIV infection in France. Antivir Ther. 2007;12:89–96.
   PubMed Web of Science ®Google Scholar
• Chadborn TR, Delpech VC, Sabin CA, Sinka K, Evans BG. The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000–2004). AIDS 2006;20:2371–9.
   PubMed Web of Science ®Google Scholar
• de Olalla PG, Mazardo C, Sambeat MA, Ocaña I, Knobel H, Humet V, . Epidemiological characteristics and predictors of late presentation of HIV infection in Barcelona (Spain) during the period 2001–2009. AIDS Res Ther. 2011;8:22.
   PubMed Web of Science ®Google Scholar
• Burns FM, Imrie JY, Nazroo J, Johnson AM, Fenton KA. Why the(y) wait? Key informant understandings of factors contributing to late presentation and poor utilization of HIV health and social care services by African migrants in Britain. AIDS Care 2007; 19:102–8.
   PubMed Web of Science ®Google Scholar
• Ndiaye B, Salleron J, Vincent A, Bataille P, Bonnevie F, Choisy P, . Factors associated with presentation to care with advanced HIV disease in Brussels and Northern France: 1997–2007. BMC Infect Dis. 2011;11:11.
   PubMed Web of Science ®Google Scholar
• Smith RD, Delpech VC, Brown AE, Rice BD. HIV transmission and high rates of late diagnoses among adults aged 50 years and over. AIDS 2010;24:2109–15.
   PubMed Web of Science ®Google Scholar
• Health Protection Agency. HIV in the United Kingdom: 2011 Report. London, UK: Health Protection Services; 2011. Available at www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317131685847 (accessed 8 March 2012).
   Google Scholar
• van Veen MG, Presanis AM, Conti S, Xiridou M, Stengaard AR, Donoghoe MC, . National estimate of HIV prevalence in the Netherlands: Comparison and applicability of different estimation tools. AIDS 2011;25:229–37.
   Google Scholar
• Presanis AM, Gill ON, Chadborn TR, Hill C, Hope V, Logan L, . Insights into the rise in HIV infections, 2001 to 2008: A Bayesian synthesis of prevalence evidence. AIDS 2010;24:2849–58.
   Google Scholar
• Siegfried N, Uthman OA, Rutherford GW. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults. Cochrane Database Syst Rev. 2010;3:CD008272.
   PubMed Web of Science ®Google Scholar
• Grant AD, Bansi L, Ainsworth J, Anderson J, Delpech V, on behalf of the United Kingdom Collaborative HIV Cohort Study Group. Tuberculosis among people with HIV infection in the United Kingdom: Opportunities for prevention? AIDS 2009;23:2507–15.
   PubMed Web of Science ®Google Scholar
• Lichtenstein KA, Armon C, Buchacz K, Chmiel JS, Buckner K, Tedaldi EM, on behalf of the HIV Outpatient Study (HOPS) Investigators. Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study. Clin Infect Dis. 2010;51:435–47.
   PubMed Web of Science ®Google Scholar
• Phillips AN. Neaton J, Lundgren JD. The role of HIV in serious diseases other than AIDS. AIDS 2008;22:2409–18.
   PubMed Web of Science ®Google Scholar
• Egger M, May M, Chêne G, Phillips AN, Ledergerber B, on behalf of the ART Cohort Collaboration. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: A collaborative analysis of prospective studies. Lancet 2002;360:119–29.
   PubMed Web of Science ®Google Scholar
• Brown AE, Kall M, Smith RD, Yin Z, Hunter A, Delpech V. Auditing national HIV guidelines and policies: The United Kingdom CD4 surveillance scheme. Open AIDS Journal 2012;7. In press.
   Google Scholar
• Deeks SG, Kitchen CM, Liu L, . Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 2004;104:942–7.
   PubMed Web of Science ®Google Scholar
• Kelley CF, Kitchen CM, Hunt PW, . Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin Infect Dis. 2009;48:787–94.
   PubMed Web of Science ®Google Scholar
• Waters L, Fisher M, Anderson J, Wood C, Delpech V, Hill T, on behalf of the UK CHIC Steering Committee. Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: Late presenters vs. late starters. HIV Med. 2011;12:289–98.
   PubMedGoogle Scholar
• Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006;20:1447–50.
   PubMed Web of Science ®Google Scholar
• Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, . Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000; 342:921–9.
   PubMed Web of Science ®Google Scholar
• Siegfried N, van der Merwe L, Brocklehurst P, Sint TT. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev. 2011;7:CD003510.
   Google Scholar
• Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, . Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493–505.
   PubMed Web of Science ®Google Scholar
• Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: Systematic review and meta-analysis. AIDS 2009;23:1397–404.
   PubMed Web of Science ®Google Scholar
• Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model. Lancet 2009;373:48–57.
   PubMed Web of Science ®Google Scholar
• Weinhardt LS, Carey MP, Johnson BT, Bickham NL. Effects of HIV counseling and testing on sexual risk behavior: A meta-analytic review of published research, 1985–1997. Am J Public Health 1999;89:1397–405.
   PubMed Web of Science ®Google Scholar
• Crepaz N, Marks G, Liau A, Mullins MM, Aupont LW, Marshall KJ, . Prevalence of unprotected anal intercourse among HIV-diagnosed MSM in the United States: A meta-analysis. AIDS 2009;23:1617–29.
   PubMed Web of Science ®Google Scholar
• Fox J, White PJ, Macdonald N, Weber J, McClure M, Fidler S, . Reductions in HIV transmission risk behaviour following diagnosis of primary HIV infection: A cohort of high-risk men who have sex with men. HIV Med. 2009;10:432–8.
   PubMed Web of Science ®Google Scholar
• Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: Implications for HIV prevention programs. JAIDS 2005;39:446–53.
   Google Scholar
• Levy AR, James D, Johnston KM, Hogg RS, Harrigan PR, Harrigan BP, . the direct cost of HIV/AIDS care. Lancet Infect Dis. 2006;6:171–7.
   PubMed Web of Science ®Google Scholar
• Krentz HB, Gill MJ. The direct medical costs of late presentation (<350/mm3) of HIV infection over a 15-year period. AIDS Res Treat. 2012;2012:757135.
   PubMedGoogle Scholar
• Delpierre C, Cuzin L, Lert F. Routine testing to reduce late HIV diagnosis in France. Br Med J. 2007;334:1354–6.
   PubMed Web of Science ®Google Scholar
• Mikolajczak J, Hospers HJ, Kok G. Reasons for not taking an HIV-test among untested men who have sex with men: An Internet study. AIDS Behav. 2006;10:431–5.
   PubMed Web of Science ®Google Scholar
• Fakoya I, Reynolds R, Caswell G, Shiripinda I. Barriers to HIV testing for migrant black Africans in Western Europe. HIV Med. 2008;9:23–5.
   PubMed Web of Science ®Google Scholar
• Deblonde J, De Koker P, Hamers FF, Fontaine J, Luchters S, Temmerman M. Barriers to HIV testing in Europe: a systematic review. Eur J Public Health 2010;20:422–32.
   PubMed Web of Science ®Google Scholar
• Mahajan AP, Sayles JN, Patel VA, Remien RH, Sawires SR, Ortiz DJ, . Stigma in the HIV/AIDS epidemic: A review of the literature and recommendations for the way forward. AIDS 2008;22:S67–79.
   PubMed Web of Science ®Google Scholar
• Chen JY, Tian H, Dahlin-Lee E, Everhard F, Mayer K. HIV testing and monitoring in privately insured members recently diagnosed with potential AIDS defining events. February 2009. 16th Conference on Retroviruses and Opportunistic Infections. Poster 1044. Available at www.retroconference.org/2009/PDFs/1044.pdf (accessed 8 March 2012).
   Google Scholar
• Liddicoat RV, Horton NJ, Urban R, Maier E, Christiansen D, Samet JH. Assessing missed opportunities for HIV testing in medical settings. J Gen Intern Med. 2004;19:349–56.
   PubMed Web of Science ®Google Scholar
• Burns FM, Johnson AM, Nazroo J, Ainsworth J, Anderson J, Fakoya A, . Missed opportunities for earlier HIV diagnosis within primary and secondary healthcare settings in the UK. AIDS 2008;22:115–22.
   PubMed Web of Science ®Google Scholar
• Warwick Z. Barriers to the implementation of the UK HIV testing guidelines in secondary care: How many are medical? Int J STD AIDS 2010;21:205–6.
   Google Scholar
• Emerson CR, Goldberg H, Vollmer-Conna U, Post JJ. Self-reported HIV testing practice among physicians treating tuberculosis in Australia and New Zealand. Int J STD AIDS 2010;21:346–50.
   PubMed Web of Science ®Google Scholar
• Alpert PL, Shuter J, DeShaw MG, Webber MP, Klein RS. Factors associated with unrecognized HIV-1 infection in an inner-city emergency department. Ann Emerg Med. 1996;28:159–64.
   PubMed Web of Science ®Google Scholar
• European Collaborative Study. The mother-to-child HIV transmission epidemic in Europe: Evolving in the East and established in the West. AIDS 2006; 20:1419–27.
   PubMed Web of Science ®Google Scholar
• Palfreeman A, Fisher M, Stewart E. HIV testing in primary care will help improve early diagnosis. Practitioner 2009;253:27–30.
   Google Scholar
• Leutscher PD, Laursen T, Andersen B, Ostergaard L, Laursen A, Larsen CS. HIV late presenters in Denmark: Need for increased diagnostic awareness among general practitioners. Dan Med Bull. 2011;58:A4253.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. HIV testing: Increasing uptake and effectiveness in the European Union. Stockholm, Sweden: ECDC; 2010. Available at http://ecdc.europa.eu/en/publications/Publications/101129_GUI_HIV_testing.pdf (accessed 8 March 2012).
   Google Scholar
• World Health Organization. Scaling up HIV testing and counselling in the WHO European region as an essential component of efforts to achieve universal access to HIV prevention, treatment, care and support. Policy framework. Geneva, Switzerland: World Health Organization; 2010. Available at www.euro.who.int/__data/assets/pdf_file/0007/85489/E93715.pdf (accessed 8 March 2012).
   Google Scholar
• British HIV Association, British Association for Sexual Health and HIV, and British Infection Society. UK National Guidelines for HIV Testing 2008. London, UK: British HIV Association; 2008. Available at www.bhiva.org/documents/Guidelines/Testing/GlinesHIVTest08.pdf (accessed 8 March 2012).
   Google Scholar
• Haute Autorité de Santé. Dépistage de l'infection par le VIH en France—Stratégies et dispositif de dépistage. Saint-Denis La Plaine (France): Haute Autorité de Santé; 2009. Available at www.has-sante.fr/portail/upload/docs/application/pdf/2009-10/synthese_depistage_vih_volet_2_vfv_2009-10-21_16-48-3_460.pdf (accessed 8 March 2012).
   Google Scholar
• Health Protection Agency. Time to test for HIV: Expanding HIV testing in healthcare and community services in England. Final report, 2011. London, UK: Health Protection Agency; 2011. Available at www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1316424799217 (accessed 8 March 2012).
   Google Scholar
• Millett D, Creighton S. Increasing GPs’ understanding of HIV may affect their HIV testing rates. HIV Med. 2010;11:Abstract P284.
   Google Scholar
• Yazdanpanah Y, Sloan CE, Charlois-Ou C, Le Vu S, Semaille C, Costagliola D, . Routine HIV screening in France: clinical impact and cost-effectiveness. PLoS One 2010;5:e13132.
   PubMed Web of Science ®Google Scholar